Canada markets closed

Intellipharmaceutics International Inc. (I4AA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.04450.0000 (0.00%)
At close: 09:38AM CEST
Show:
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2022-11-30
2021-11-30
2020-11-30
2019-11-30
Total Revenue
904.946
65.728
0
1,402
3,481
Cost of Revenue
-
-
0
0
33.068
Gross Profit
-
-
0
1,402
3,447
Operating Expenses
Research Development
2,060
2,149
2,662
3,517
6,609
Selling General and Administrative
774.854
561.05
1,250
2,147
4,168
Total Operating Expenses
3,009
2,916
4,173
6,080
11,282
Operating Income or Loss
-1,723
-2,851
-4,173
-4,678
-7,835
Interest Expense
234.097
291.619
549.299
969.653
247.516
Total Other Income/Expenses Net
-354.672
255.069
-536.967
2,290
-21.079
Income Before Tax
-2,312
-2,887
-5,259
-3,358
-8,090
Income Tax Expense
-
5.337
-114.187
32.833
-5.364
Income from Continuing Operations
-2,318
-2,892
-5,145
-3,391
-8,085
Net Income
-3,174
-2,892
-5,145
-3,391
-8,085
Net Income available to common shareholders
-3,174
-2,892
-5,145
-3,391
-8,085
Basic EPS
-0.09
-0.09
-0.17
-0.14
-0.37
Diluted EPS
-0.09
-0.09
-0.17
-0.14
-0.37
Basic Average Shares
36,752
33,093
29,430
23,562
21,580
Diluted Average Shares
36,752
33,093
29,430
23,562
21,580